Thread: acquisition of Modus Outcomes
Decentralized trial tech firm Thread has acquired Modus Outcomes, a research consultancy. The acquisition reportedly is intended to join Thread’s eCOA platform with Modus’s service to help advance CRO decision-making and advance new therapies.
Thread CEO John Rites said, “With more sophisticated scientific designs, larger global scale and a greater focus on highly targeted patient subpopulations, the biopharmaceutical industry is increasingly shifting to DCT’s. Combining Modus’ industry-leading scientific and eCOA expertise with our technology platform enhances our solutions and advances our mission of providing customers with one comprehensive platform, delivering five times more inclusive research and enabling 30% more efficient DCTs.”
